Related Experiment Video
Updated: Feb 7, 2026

Colon Ascendens Stent Peritonitis CASP - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Discharge Plasma-Activated Saline Protects Against Abdominal Sepsis by Promoting Bacterial Clearance
Jingyao Zhang1,2, Kai Qu1, Xia Zhang3
1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Shaanxi, People's Republic of China.
Aim:
The aim of the present study was to investigate the effect of cold atmospheric discharge plasma-activated saline (DPAS) on abdominal sepsis.
Methods:
For in vitro research, Methicillin-resistant Staphylococcus aureus (MRSA) was treated with DPAS, and the survival was detected. For in vivo research, male C57BL/6 mice were induced to sepsis by cecal ligation and puncture (CLP) and were randomly allocated into saline and DPAS control groups, CLP group, and low or high doses of DPAS (CLP + DPAS 5 and CLP + DPAS 10) groups. In experiment 1, mice were monitored for 120 h to conduct a Kaplan-Meier survival curve analysis. In experiment 2, blood, peritoneal fluid, and lung and intestinal tissues in experimental groups were collected at 4, 8, and 24 h after the CLP/sham operation to determine the severity of sepsis.
Results:
In vitro results showed that DPAS significantly inhibited MRSA proliferation. In vivo results showed that both low and high doses of DPAS could significantly improve septic survival in the mice. DPAS treatment also significantly attenuated the lung and intestine histopathological injuries; lung wet/dry ratio; inflammatory reaction; bacterial load in the peritoneal cavity, blood, and lungs; HMGB1 and NF-κB p65 expression levels; cell apoptosis in the lung and intestine. However, there was no difference between CLP + DPAS 5 and CLP + DPAS 10 groups.
Conclusion:
In conclusion, DPAS had markedly protective effects on abdominal sepsis in mice, and the potential mechanism was associated with the ability of reactive species in DPAS to promote bacterial clearance, inhibit the inflammatory response and cell apoptosis.
Insights
Cold atmospheric discharge plasma-activated saline (DPAS) effectively treats abdominal sepsis in mice by inhibiting bacterial growth and reducing inflammation. This innovative treatment shows significant protective effects against sepsis-induced organ damage and improves survival rates.
Area of Science:
- Plasma medicine
- Infectious disease research
- Sepsis treatment
Background:
- Abdominal sepsis remains a critical condition with high mortality.
- Current treatments for sepsis have limitations.
- Plasma-activated saline (DPAS) is an emerging therapeutic modality.
Purpose of the Study:
- To investigate the efficacy of cold atmospheric discharge plasma-activated saline (DPAS) in treating abdominal sepsis.
- To evaluate the in vitro and in vivo effects of DPAS on bacterial proliferation and sepsis progression.
- To elucidate the underlying mechanisms of DPAS in mitigating sepsis-related pathology.
Main Methods:
- In vitro: Methicillin-resistant Staphylococcus aureus (MRSA) treated with DPAS.
- In vivo: Murine model of abdominal sepsis induced by cecal ligation and puncture (CLP).
- Assessment of survival rates, histopathological injuries, inflammatory markers, bacterial load, and molecular signaling pathways (HMGB1, NF-κB p65).
Main Results:
- DPAS significantly inhibited MRSA proliferation in vitro.
- DPAS treatment improved survival rates in a murine sepsis model.
- DPAS attenuated organ damage, reduced inflammation, decreased bacterial load, and suppressed HMGB1 and NF-κB p65 expression.
Conclusions:
- DPAS demonstrates significant protective effects against abdominal sepsis in mice.
- The therapeutic potential of DPAS is attributed to enhanced bacterial clearance and modulation of inflammatory responses.
- DPAS represents a promising novel therapeutic strategy for abdominal sepsis.
Related Concept Videos
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
The Eukaryotic Promoter Region
RC Circuits: Discharging A Capacitor
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Abdominal Aorta
The celiac trunk, a singular artery, divides into the left gastric artery, which...

